Dai-ichi Life, Itochu Technology Ventures, Koshidaka and Toyoshima CVC were among the investors that backed the medical therapy booking platform’s $19.3m round.
Japan-based medical treatment app provider CureApp has raised ¥2.1bn ($19.3m) from investors including corporates Dai-ichi Life, Itochu, Koshidaka and Toyoshima & Co, taking its total funding to roughly $58.8m.
Financial services firms Shoko Chukin Bank and Sumitomo Mitsui Banking Corporation (SMBC) also took part in the round, as did Healthcare Innovation, Saisei Ventures and Sumitomo Mitsui Trust Investment’s Japan Co-Investment III.
Insurer Dai-ichi Life and holding group Koshidaka participated directly, while conglomerate Itochu, textile trader Toyoshima & Co and SMBC…
